Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Sep 27, 2019
Alert -- Chinese Stocks Hit the Skids
Image Source: Michael Vadon. We don’t think US and China are anywhere close to any sort of meaningful trade agreement, regardless of what you hear from the White House. The latest move in this high-stakes trade war by the US may be to de-list Chinese stocks. This actually happening seems surreal given the implications on U.S. investors, but given weakness in US-listed Chinese names, the market is factoring in some probability of this occurring. Sep 27, 2019
Dividend Increases/Decreases for the Week Ending September 27
Let's take a look at companies that raised/lowered their dividend this week. Sep 26, 2019
Hold ‘em or Fold ‘em?
Let’s talk Cardinal Health, Hanesbrands, Ford and Verint in this piece. Our best ideas are ideas in the newsletter portfolios. Unlike other widely followed strategies, the Valuentum strategy likes to capture the entire pricing cycle on an idea. We don’t “operate” in ideas only below the ‘undervalued’ line, but we like to let our winners run to when they are overvalued and showing signs of technical/momentum deterioration. Sep 26, 2019
Nike Posts a Solid Quarter and Issues Strong Guidance
Image Shown: Shares of Nike Inc pop on September 25 after reporting a strong first quarter for fiscal 2020 and issuing favorable guidance for the full fiscal year.Nike reported earnings for the first quarter of its fiscal 2020 (ended August 31) on September 24 and investors clearly liked what they saw. The firm has been performing quite well given foreign currency headwinds and the ongoing US-China trade war, and it’s clear that hasn’t undermined core demand for its popular sportswear and equipment products. We are still staying on the sidelines given how shares of NKE are richly valued, in our view. Sep 25, 2019
Best Ideas Newsletter Portfolio Holding PayPal Can Thrive in a Post-eBay World
Image Source: PayPal Holdings Inc -- IR Presentation. We continue to like Best Ideas Newsletter portfolio holding PayPal Holdings as a way to gain exposure to the very attractive payment processing and financial technology industry, complementing our top-weighted Visa holding. PayPal can do more than just survive in a post-eBay world, it can thrive. Sep 24, 2019
The Orthodontics Industry Is Getting Disrupted
Image Source: SmileDirectClub Inc - S-1 SEC Filing. SmileDirectClub, the teledentistry startup that makes 3D-printed clear aligners which are a cheaper alternative to braces (albeit with drawbacks when compared to the traditional braces route), went public this September at $23/share. While SmileDirectClub’s growth trajectory is quite intriguing, we prefer to wait until we get a better idea of the regulatory landscape the start-up faces and what its financial performance will look like now that it’s a public entity in the limelight. For Align, we are staying firmly away from the company as competitive pressures will continue to mount going forward. Neither company pays out a common dividend at this time. Sep 23, 2019
Empirical Support for Porter’s “Gospel,” Plus Comments on the “Head Fake” Rotation
“Let’s be very clear: There is strong empirical quantitative evidence that the price-to-fair value equation (“factor”) is predictive of returns, which is what matters for value investors, and in Morningstar’s case, the moat assessment is just part of that overarching conclusion (fair value estimate). Researchers continue to attack the moat “factor” on grounds that don’t make any sense, in my view, and are cherry-picking parameters to assess value investing.” – Brian Nelson, CFA Sep 22, 2019
Jim Chanos Attacks DaVita and Throws Shade at Warren Buffett
DaVita is a midsized kidney dialysis company with strong free cash flows. However, the company is coming under fire from famed short seller Jim Chanos who recently threw shade at Warren Buffett. Image Source: DaVita Inc – IR Presentation. Sep 22, 2019
Our Reports on Stocks in the Medical Instruments Group
Image Source: Christian C. We've optimized our healthcare coverage. Sep 20, 2019
Dividend Increases/Decreases for the Week Ending September 20
Let's take a look at companies that raised/lowered their dividend this week.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267268269270271272273274275276277278279280 281282283284285286287288289290291292293294295296297298299300 301302303304305306307308309310311312313314315316317318319320 321322323324325326327328329330331332333334335336337338339340 341342343344345346347348349350351352353354355356357358359360 361362363364365366367368369370371372373374375376377378379380 381382383384385386387388389390391392393394395396397398399400 401402403404405406407408409410411412413414415416417418419420 421422423424425426427428429430431432433434435436437438439440 441442443444445446447448449450451452453454455456457458459460 461462463464465466467468469470471472473474475476477478479480 481482483484485486487488489490491492493494495496497498499500 501502503504505506507508509510511512513514515516517518519520 521522523524525526527528529530531532533534535536537538539540 541542543544545546547548549550551552553554555556557558559560 561562563564565566567568569next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|